Jia En Wu

956 citations
12 papers · 210 indexed · h-index 6
Topics
Antibiotic Use and Resistance (6 papers)Bacterial Identification and Susceptibility Testing (4 papers)Urinary Tract Infections Management (2 papers)

In The Last Decade

Jia En Wu

11 papers receiving 209 citations

Peers

Jia En Wu
Comparison fields: 5 of 42
  • Applied Microbiology and Biotechnology 97
  • Molecular Biology 69
  • Cancer Research 47
  • Clinical Biochemistry 43
  • Epidemiology 42
Replace M. Fellhauer with:
M. Fellhauer Germany
Karine Bézulier France
Rebekah Wrenn United States
Rosaria Lionello Italy
Jon Hiles United States
Valerie Cluzet United States
O. O. Lyulko Germany
Firas Koura United States
Cristina Badía Spain
Ee Hui Goh Singapore
Jia En Wu relative to M. Fellhauer Germany M. Fellhauer's profile →
Citations per field
00.5×11.8×
M. Fellhauer · 1×
Citations per year

Countries citing papers authored by Jia En Wu

Since Specialization
Citations

This map shows the geographic impact of Jia En Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jia En Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jia En Wu more than expected).

Fields of papers citing papers by Jia En Wu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jia En Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jia En Wu. The network helps show where Jia En Wu may publish in the future.

Co-authorship network of co-authors of Jia En Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Jia En Wu. A scholar is included among the top collaborators of Jia En Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jia En Wu. Jia En Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
#WorkIndexed citations
1 3
2 3
3 0
4 4
5 1
6 28
7 1
8
CASZ1 is a novel promoter of metastasis in ovarian cancer.
9
9 62
10 13
11 73
12 13

About Jia En Wu

Jia En Wu is a scholar working on Applied Microbiology and Biotechnology, Clinical Biochemistry and Molecular Medicine, having authored 12 papers that have together received 210 indexed citations. Recurring topics across this work include Antibiotic Use and Resistance (6 papers), Bacterial Identification and Susceptibility Testing (4 papers) and Urinary Tract Infections Management (2 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (97 citations), Molecular Medicine (40 citations) and Clinical Biochemistry (43 citations). Jia En Wu has collaborated with scholars based in Singapore, China and United States. Frequent co-authors include Li Yang Hsu, Douglas S. Chan, Feng Lü, Jun Li, Chao Tian, Lina Hu, Li Liu, Tat Ming Ng, Paul Anantharajah Tambyah and David Chien Lye. Their work appears in journals such as International Journal of Antimicrobial Agents, Antibiotics and Virulence.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026